Beruflich Dokumente
Kultur Dokumente
(as of 31/01/2006)
Expectation of losses (not due to credit deterioration) No fixed or determinable payments (equity instruments) or Designated as AFS
no
yes
Compound instrument
yes
Contractual obligation to deliver cash or another financial asset or to exchange financial instruments under unfavourable conditions
no
no no
available-for-sale (AFS)
held-to-maturity (HTM)
equity
( ) ( )
LAC
AFV
AFS
LAR
HTM
LFV
LAC
Amortised Cost IAS 39.9 and Regular Way Contracts IAS 39.38
Amortised Cost: Amount at which the financial asset or financial liability is measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount, and minus any reduction (directly or through the use of an allowance account) for impairment or uncollectibility. Transaction Cost: Incremental cost that is directly attributable to the acquisition of a financial asset or issue of a financial liability. Effective Interest Rate: Rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial instrument or, when appropriate, a shorter period to the net carrying amount of the financial asset or financial liability. When calculating the effective interest rate, an entity shall estimate cash flows considering all contractual terms of the financial instrument but shall not consider future credit losses. The calculation includes all fees and points paid or received between parties to the contract that are an integral part of the effective interest rate (see IAS 18), transaction costs, and all other premiums or discounts. Regular Way Contracts: Regular way purchases or sales shall be (de-)recognised using trade date or settlement date accounting consistently for each category.
AFS
HTM
AFS
LAR
fair value plus transaction cost
LFV
fair value
LAC
fair value plus transaction cost amortised cost recognised in profit or loss not recognised
Fair Value Measurement Consideration Financial instrument is quoted in an active market, if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or regulatory agency and represent actual and regularly occurring market transactions.
no yes
fair value in profit or loss (implicit) recognised in profit or loss in profit or loss (implicit) in profit or loss (implicit)
amortised cost recognised in profit or loss not recognised recognised in profit or loss recognised in profit or loss
fair value in profit or loss (implicit) recognised in profit or loss yes, specific to that financial liability
Use of market prices: bid price for an asset held; asking price for a liability held; mid-market prices for an offsetting risk position.
Investments in equity instruments that do not have a quoted market price in an active market and derivatives hereon and the range of reasonable fair value estimates is significant and probabilities of various estimates cannot be reasonably assessed.
no
yes
An entity is precluded from measuring the instrument at fair value. Rather the unquoted equity instrument is measured at cost.
no
no
yes
Individual assessment (specific allowance) present value of expected future cash flows (using effective interest) recognise unwinding for each single loan as interest income
Assessment for impairment on portfolio basis considering the loss identification period (LIP) (portfolio allowance for non-impaired loans) E x PD x LGD x LIP (E: exposure at balance sheet date; LGD: loss given default; PD: probability of default < 1) recognise contractual interest (no unwinding) impairment trigger event
Collective loan assessment (portfolio allowance for insignificant loans)) present value of future cash flows in portfolio or E x PD x LGD; PD=1 recognise unwinding on portolio basis
yes
Fair value is not less than the amount payable on demand, discounted from the first date that the amount could be required to be paid. The valuation technique incorporates all factors that market participants would consider, i.e. time value of money, credit risk, foreign currency exchange rates etc. is consistent with accepted economic methodologies for pricing financial instruments and is calibrated and tested for its validity (back-testing). No recognition of day one profits or losses.
not recognised
Use of valuation techniques: use of recent arms length market transactions; reference to the current fair value of another instrument that is substantially the same; discounted cash flow analysis [short-term receivables and payables with no stated interest rate may be measured at the original invoice amount if the effect of discounting is immaterial]; option pricing models.
according to IAS 21
Ineffective part ( fv) Balance sheet amount according to IAS 21 according to the category no recognition of the forecast transaction2)
1) Accounted for similarly to cash flow hedges. 2) If the forecasted transaction results in the recognition of a non-financial asset/liability, the associated gains and losses that were recognised directly in equity may be included in the initial cost or other carrying amount of the asset or liability (basis adjustment).
Disclosures IFRS 7
Disclosure requirements include: carrying amounts of each of the categories, as defined in IAS 39, either on the face of the balance sheet or in the notes; for a loan designated as AFV: - maximum exposure to credit risk; - amount mitigated by related credit derivatives or similar instruments; - change in fair value of the loan attributable to changes in the credit risk; - change in fair value of related credit derivatives or similar instruments; for a financial liability designated as LFV: - change in fair value attributable to changes in the credit risk of that liability; - difference between carrying amount and maturity amount; reclassification: amount reclassified into and out of each category and the reason for that reclassification; derecognition: disclosures of transfers that do not (completely) qualify for derecognition; collateral: carrying amount of financial assets pledged as collateral for (contingent) liabilities; and fair value of the collateral held; allowance account for credit losses: reconciliation of changes in the allowance account during the period for each class of financial assets; compound financial instruments with multiple embedded derivatives: existence of those features; defaults and breaches for loans payable: details of any defaults; carrying amount; whether the default was remedied, or terms were renegotiated; net gains or net losses on financial assets or financial liabilities in each of the categories, as defined in IAS 39; total interest income and total interest expense (calculated using the effective interest method) for LAR, HTM, AFS and LAC; fee income and expense arising from financial assets or financial liabilities other than AFV and LFV; and trust and other fiduciary activities; interest income on impaired financial assets accrued in accordance with IAS 39.AG93; amount of any impairment loss for each class of financial asset; accounting policies (criteria for designating AFV/LFV; for regular way contracts whether trade date or settlement date accounting is applied; impairment policy; determination of net gains or net losses on each category etc.); hedge accounting: description of each type of hedge; gains and losses recognised in profit or loss (ineffectiveness); fair value and carrying amounts of each class of assets and liabilities; methods and valuation techniques; reference to published price quotations; exposures to risk and how they arise; objectives, policies and processes for managing the risk and the methods used to measure the risk; summary quantitative data about exposure to that risk at the reporting date; concentrations of risk; credit risk: - maximum exposure to credit risk without taking account of any collateral held or other credit enhancements; - credit quality of financial assets that are neither past due nor impaired; - analysis of financial assets that are either past due or impaired; - collateral and other credit enhancements obtained; liquidity risk: maturity analysis for financial liabilities that shows the remaining contractual maturities; and a description of how the entity manages the liquidity risk inherent; market risk: sensitivity analysis for each type of market risk to which the entity is exposed (such as value-at-risk) including explanation of methods.
no
no
no
Exchange between an existing borrower and lender of debt instruments with substantially different terms
no
yes
Terms are substantially different if: the discounted present value of the cash flows under the new terms, including any fees paid net of any fees received and discounted using the original effective interest rate, is at least 10 per cent different from the original financial liability
yes no
*connectedthinking
Continued recognition of the asset to the extent of the entitys continuing involvement
No derecognition
StB Dr. Katja Barz WP Burkhard Eckes WP StB Peter Flick WP CPA Dr. Caroline Sittmann-Haury WP StB Wolfgang Weigel